Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Pemvidutide

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pemvidutide Shows Metabolic Improvements in MASH at EASL'26
    Pemvidutide Shows Metabolic Improvements in MASH at EASL'26

    28 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/28/3303064/0/en/pemvidutide-demonstrates-significant-metabolic-improvements-in-patients-with-mash-in-new-48-week-impact-phase-2b-data-presented-at-easl-2026.html

    GLOBENEWSWIRE
    28 May 2026
    Share Share
    Pemvidutide Shows Fibrosis Regression in MASH at EASL 2026
    Pemvidutide Shows Fibrosis Regression in MASH at EASL 2026

    27 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/27/3301887/0/en/new-impact-phase-2b-data-highlight-concurrent-improvements-across-multiple-non-invasive-markers-and-qfibrosis-measured-fibrosis-regression-with-pemvidutide-in-mash-at-easl-2026.html

    GLOBENEWSWIRE
    27 May 2026
    Share Share
    Altimmune To Present Pemvidutide Results In MASH At EASL
    Altimmune To Present Pemvidutide Results In MASH At EASL

    13 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/13/3293871/0/en/altimmune-to-present-results-of-pemvidutide-in-mash-in-an-oral-presentation-and-multiple-poster-presentations-at-easl-congress-2026.html

    GLOBENEWSWIRE
    13 May 2026
    Share Share
    Altimmune Reports Q1 2026 Results and Business Update on May 13
    Altimmune Reports Q1 2026 Results and Business Update on May 13

    06 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/06/3288706/0/en/altimmune-to-report-first-quarter-2026-financial-results-and-provide-business-update-on-may-13-2026.html

    GLOBENEWSWIRE
    06 May 2026
    Share Share
    Altimmune Announces Proposed Underwritten Public Offering
    Altimmune Announces Proposed Underwritten Public Offering

    22 Apr 2026

    // PRESS RELEASE

    https://ir.altimmune.com/news-releases/news-release-details/altimmune-announces-proposed-underwritten-public-offering

    PRESS RELEASE
    22 Apr 2026
    Share Share
    Altimmune Unveils 2025 Financial Results And Business Updates
    Altimmune Unveils 2025 Financial Results And Business Updates

    05 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/05/3250009/0/en/Altimmune-Announces-Fourth-Quarter-and-Full-year-2025-Financial-Results-and-Business-Updates.html

    GLOBENEWSWIRE
    05 Mar 2026
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.